Clinical Trials
3 trialsNCT00422097 2016-03-10
A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer
R-Pharm
Phase 1 Completed
NCT00851448 2011-06-02
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
Fresenius Kabi
Phase NA Terminated
NCT01025167 2010-08-20
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
Fresenius Kabi
Phase NA Completed